| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/06/2007 | CN1976722A 活性物质联合 Active substances combined |
| 06/06/2007 | CN1974570A Fused pyrrolocarbazoles against inflammation |
| 06/06/2007 | CN1973876A Chinese medicine for treating kidney deficiency and its prpen |
| 06/06/2007 | CN1973872A Medicine for nourishing Yin, invigorating kidney, strengthening physique and nourishing brain and its prepn |
| 06/06/2007 | CN1973864A Medicine composition for treating hematuria and nephropyelitis and its prepn |
| 06/06/2007 | CN1973855A Motherwort injection |
| 06/06/2007 | CN1973854A Process of preparing motherwort injection |
| 06/06/2007 | CN1973849A Medicine composition for inducing diuresis to treat stranguria and its prepn process |
| 06/06/2007 | CN1319981C Preparation process of plantago fotal glycocide and its application in medicine |
| 06/06/2007 | CN1319963C Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid |
| 06/06/2007 | CN1319961C Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 06/06/2007 | CN1319945C Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof |
| 06/06/2007 | CN1319565C Chinese medicine for treating urinary system calculus |
| 06/06/2007 | CN1319547C Chinese medicine formulation for treating prostatic proliferation |
| 06/06/2007 | CN1319534C Lycopene and coenzyme Q#-[10] containing formulation and its manufacturing method |
| 06/06/2007 | CN1319533C Cefetamet pivoxil hydrochloride dispersion dispersion tablets and preparation method |
| 06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 06/05/2007 | US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 06/05/2007 | US7226995 Use of C-reactive protein to treat immune complex-mediated renal disease |
| 06/05/2007 | US7226945 Estrogen receptor-β ligands |
| 06/05/2007 | US7226924 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use |
| 06/05/2007 | US7226921 An enzyme inhibitor of cysteine proteases, a morpholine-4-carboxyamide 1,3,4-oxadiazole derivatives; for treating arthritis, muscular dystrophy, inflammation, tumor, glomerulonephritis, malaria, periodontal disease |
| 05/31/2007 | WO2007061074A1 Novel bisboron compound |
| 05/31/2007 | WO2007061029A1 Therapeutic agent for prostate cancer |
| 05/31/2007 | WO2007060974A1 Pharmaceutical for use in the treatment of ureterolithiasis |
| 05/31/2007 | WO2007042669A3 Derivatives of 4-amino-quinazoline, preparation method thereof and use of same in therapeutics |
| 05/31/2007 | WO2007042660A3 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof |
| 05/31/2007 | WO2007037554A9 Adsorbent for advanced glycation endproducts |
| 05/31/2007 | WO2007003957A3 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 05/31/2007 | WO2006110496A3 Activation of sodium potassium atpase |
| 05/31/2007 | US20070124837 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/31/2007 | US20070123521 Cinnamoyl derivatives and use thereof |
| 05/31/2007 | US20070122381 Method for regulating neuron development and maintenance |
| 05/31/2007 | CA2631017A1 Bisboron compounds for use as intracellular calcium concentration increase inhibitors |
| 05/31/2007 | CA2628476A1 Pharmaceutical for use in the treatment of ureterolithiasis |
| 05/30/2007 | EP1790655A2 Biologically active peptides |
| 05/30/2007 | EP1790652A1 Polycyclic guanine phosphodiesterase V inhibitors |
| 05/30/2007 | EP1790651A1 A1 adenosine receptor antagonists |
| 05/30/2007 | EP1790644A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/30/2007 | EP1790640A1 Novel imidazolidine derivative and use thereof |
| 05/30/2007 | EP1790636A1 Piperidine derivatives and use thereof |
| 05/30/2007 | EP1790353A1 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 05/30/2007 | EP1790352A1 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
| 05/30/2007 | EP1789436A1 Antibacterial peptides and analogues thereof |
| 05/30/2007 | EP1789051A1 Endothelin a receptor (eta) antagonists in combination with phosphodiesterase 5 inhibitors (pde5) and uses thereof |
| 05/30/2007 | EP1789047A2 Treatment of diseases using nalmefene and its analgos |
| 05/30/2007 | EP1789030A2 Medical implant provided with inhibitors of atp synthesis |
| 05/30/2007 | EP1789029A2 Methods and compositions for the treatment of cell proliferation |
| 05/30/2007 | EP1556372B1 Substituted 4-amino-1-(pyridylmethyl) piperidine as muscarinic receptor antagonists |
| 05/30/2007 | EP1538888A4 Upper hitch link |
| 05/30/2007 | EP1499577B1 2-(2,6-dichlorophenyl)-diarylimidazoles |
| 05/30/2007 | EP1385527B1 Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof |
| 05/30/2007 | EP1311663B1 Claudin polypeptides |
| 05/30/2007 | EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 05/30/2007 | EP1248615B1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/30/2007 | EP1180103B1 Renin inhibitors |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | CN1972910A 内酰胺速激肽受体拮抗剂 Lactam tachykinin receptor antagonists |
| 05/30/2007 | CN1972698A Beta-hydroxy short to medium chain fatty acid polymer |
| 05/30/2007 | CN1970538A 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 05/30/2007 | CN1970065A Medicament for treating hyperplasia of prostate |
| 05/30/2007 | CN1970025A Chinese medicinal biological agent of 'Liu Wei Di Huang' decoction and preparation process thereof |
| 05/30/2007 | CN1969981A Chinese medicine for treating calculi and preparation process thereof |
| 05/30/2007 | CN1969975A Formulation for replenishing qi, regenerating blood, tonigying kidney and nourishing face and method for preparing same |
| 05/30/2007 | CN1969858A Pharmaceutical composition for treating poultry kidney enlargement |
| 05/30/2007 | CN1969836A Ferulic acid and sodium ferulate preparation for inducing stem cell differentiating into nerve stem cell and pharmaceutical application thereof |
| 05/30/2007 | CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 05/30/2007 | CN1318416C Indazole amide compounds as 5-serotoninergic agents |
| 05/30/2007 | CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 05/30/2007 | CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 05/30/2007 | CN1318084C Neuroprotective peptides |
| 05/29/2007 | WO2006034832A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |
| 05/29/2007 | US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation |
| 05/29/2007 | US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents |
| 05/29/2007 | US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 05/29/2007 | US7223760 Substituted triazole compounds |
| 05/29/2007 | US7223752 Biphenyl vasopressin agonists |
| 05/29/2007 | US7223563 Nucleic acids; diagnosing and treating hypophosphatemic disorders; diagnosing tumor induced osteomalacia |
| 05/29/2007 | US7223424 Comprising aliquot of the herb Herba Epimedii and aliquot of three supplemental herbs selected from Fructus Rosae Laevigatae, Fructus Rubi, Fructus Psoralea, Radix Morindae Officinalis, Fructus Schisandrac Chinensis, and others |
| 05/29/2007 | US7223394 Human antibodies that bind human TNFα |
| 05/29/2007 | CA2214565C New cryptophycins from synthesis |
| 05/24/2007 | WO2007059021A1 Soft anticholinergic zwitterions |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007057466A1 Rapamycin derivative or an impdh inhibitor for treating polycystic kidney disease |
| 05/24/2007 | WO2007056941A1 The use of isothiocyanates compounds in treating prostatic diseases and skin cancer |
| 05/24/2007 | WO2007047430A3 Method of treating acute failure with thrombomodulin variant |
| 05/24/2007 | WO2007037513A9 Aryl-substituted nitrogen-containing heterocyclic compound |
| 05/24/2007 | WO2007016352A3 Oral liquid losartan compositions |
| 05/24/2007 | WO2006116302A3 High-potency botulinum toxin formulations |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117790 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/24/2007 | US20070117754 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 05/24/2007 | US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/24/2007 | US20070116782 Use of rare earth compounds for the prevention of kidney stone disease |
| 05/24/2007 | US20070116708 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | CA2628175A1 Rapamycin derivative or an impdh inhibitor for treating polycystic kidney disease |
| 05/24/2007 | CA2627982A1 Soft anticholinergic esters |